Elsevier

Metabolism

Volume 46, Issue 4, April 1997, Pages 410-413
Metabolism

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men

https://doi.org/10.1016/S0026-0495(97)90057-3Get rights and content

Abstract

Cross-sectional studies have demonstrated a decline in testosterone and free and bioavailable testosterone with age. This occurs in a majority of older persons without an increase in luteinizing hormone (LH), suggesting that a component of the testosterone decrease is due to secondary hypogonadism. To determine whether these findings could be duplicated in a longitudinal study, we measured testosterone, LH, follicle-stimulating hormone (FSH), and sex hormone—binding globulin (SHBG) levels in 77 men participating in the New Mexico Aging Process Study who had sera available in 1980 or 1981 and two or more serial samples in 1982, 1984, 1989, and/or 1994. Thirty-nine subjects had samples available from both 1980 and 1994. The age at entry into the study ranged from 61 to 87 years. Testosterone levels decreased over the 15 years of the study. In persons who were alive for the duration of the study, testosterone levels were significantly lower 5 years before termination of the study (P < .05). Testosterone levels did not differ at entry into the study among those who died and those who were alive at the end of the study period. Eight of 77 subjects (10%) had LH levels above the normal range at some time during the study. In contrast, 43% of subjects had elevated FSH levels. Both LH and FSH increased significantly with age. SHBG levels were measured in 1980 and 1994 and increased significantly with age (P < .0001). LH and FSH were highly correlated with one another, but neither correlated with testosterone. This study demonstrated a longitudinal decline in testosterone and an increase in LH and FSH in older men. The average rate of decrement in testosterone concentration was 110 ng/dL every decade.

References (29)

  • A Gray et al.

    Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study

    J Clin Endocrinol Metab

    (1991)
  • FE Kaiser et al.

    Impotence and aging: Clinical and hormonal factors

    J Am Geriatr Soc

    (1988)
  • JP Deslypere et al.

    Leydig cell function in normal men: Effect of age, life-style, residence, diet, and activity

    J Clin Endocrinol Metab

    (1984)
  • HW Baker et al.

    Changes in the pituitary-testicular system with age

    Clin Endocrinol (Oxf)

    (1976)
  • Cited by (725)

    • Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

      2022, Physiology and Behavior
      Citation Excerpt :

      Sex steroid levels, which undergo substantial changes across the lifespan, may present a potential target for such preventative approaches (e.g. [20]). In men, ageing is accompanied by decreases in total testosterone (TT), free testosterone (FT), dihydrotestosterone (DHT), estradiol (E2), and dehydroepiandrosterone sulfate (DHEAS), whereas luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex hormone-binding globulin (SHBG) levels gradually increase over time [8, 33, 51]. Both androgen [38, 65, 66] and estrogen [15, 27, 64, 66] receptors are expressed throughout the brain, with a particular abundance in the hippocampus [2, 5, 30, 58].

    View all citing articles on Scopus
    View full text